Amyris Inc (NASDAQ: AMRS) is having an incredibly rough start to the trading session this morning. However, if you dig around, you’ll see that the most recent news on the stock is days old. So, why is it falling? We believe that we’ve found the answer. Today, we’ll talk about:
- Why AMRS stock is falling;
- what we’re seeing from the stock; and
- what we’ll be watching for ahead.
AMRS Stock Is Falling Hard
As mentioned above, Amyris is having a rough day in the market today. However, with no news, many are wondering why the stock is falling. Well, it seems to have to do with the days-old news mentioned above.
A couple of days ago, AMRS announced that it had received a standard notice from NASDAQ. The notice stated that, as a result of not having timely filed its annual report on Form 10-K for the year ended December 31, 2018, it is not in compliance with listing requirements.
While there is no immediate effect on AMRS as a result of the letter, the company has 60 days from the date of the letter to submit a plan to regain compliance. If the plan is accepted, it would be granted up to 180 days from the original due date of the Form 10-K, or until September 30, 2019, to regain compliance.
At the time of the release, it seemed to have no negative effect on the company. This may be because the company expalined the delays away with a need for additional time to finalize accounting for and disclosure of the transaction with koninklijke DSM N.V. that closed in November.
However, based on conversations in various social networks and message boards, investors seem to be looking for a positive update today, wondering if it’s going to take until September to actually see a report. This seems to be putting a damper on AMRS stock, sending it tumbling down.
What We’re Seeing From The Stock
At the end of the day, as investor frustration grows with regard to Amyris’ delayed financial report, the stock is feeling the pain. As is normally the case, our partners at Trade Ideas were the first to alert us to the declines. Currently (10:51), AMRS is trading at $3.08 per share after a loss of $0.67 per share or 17.87% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on AMRS. In particular, we’re interested in following the story surrounding the company’s continued efforts to get the financial report to investors. We’re also interested in following the company’s work to expand its revenue and provide value to investors. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!